Ifeoma I Ulasi, Shay Tzur, Walter G Wasser, Revital Shemer, Etty Kruzel, Elena Feigin, Chinwuba K Ijoma, Obinna D Onodugo, Julius U Okoye, Ejikeme B Arodiwe, Ngozi A Ifebunandu, Chinwe J Chukwuka, Cajetan C Onyedum, Uchenna N Ijoma, Emmanuel Nna, Macaulay Onuigbo, Saharon Rosset, Karl Skorecki
BACKGROUND: Continental Africa is facing an epidemic of chronic kidney disease (CKD). APOL1 risk variants have been shown to be strongly associated with an increased risk for non-diabetic kidney disease including HIV nephropathy, primary non-monogenic focal and segmental glomerulosclerosis, and hypertension-attributed nephropathy among African ancestry populations in the USA. The world's highest frequencies of APOL1 risk alleles have been reported in West African nations, overlapping regions with a high incidence of CKD and hypertension...
2013: Nephron. Clinical Practice